Cytosorbents Corp
CytoSorbents Announces $6.25 Million Common Stock Financing Priced At-the-Market under Nasdaq Rules and Concurrent Restructuring of Avenue Capital Credit Facility
$4.0 million registered direct offering of common stock, led by existing shareholders and management $2.25 million of Avenue debt satisfied through…
